|
The latest news briefs about our startups and us appearing on our website for the week ending 12/14/2020:
|
|
Excerpts:
A new University of Florida app will help the state’s blueberry growers identify and manage disease and insect injuries commonly encountered in Florida before their crop is ruined. Collectively, blueberries are a $60 million-per-year crop in Florida.
Read on »
UF Innovate | The Hub and UF Innovate | Sid Martin Biotech alum Pheronym, an Ag-biotech pest control company, has signed a 5-year Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Agriculture's Agricultural Research Service (USDA ARS).
Read on »
Elsevier, a global leader in research publishing and information analytics, and part of RELX, has acquired UF startup Shadow Health, a Florida-based developer of virtual simulations in nursing and healthcare education.
Read on »
Observe the Earth from space to improve the defense of the European Union. With this objective in mind, UF startup and UF Innovate | The Hub resident company SATLANTIS, a provider of high-performance payload technologies for Earth observation and remote sensing, is leading a European project to develop critical technologies with which to implement a maritime surveillance mission.
Read on »
The Florida Institute for Cybersecurity (FICS) Research is well-known and regarded as a global leader in hardware security and systems security research. FICS Research Director, Dr. Mark Tehranipoor, is generally acknowledged as the father of hardware security, in many cases having created the first programs, books, publications, and conferences in the domain.
Read on »
If you had to collect vital signs from a mountain lion, wouldn’t you prefer to do it with zero contact and at a safe distance? With Structured Monitoring Products’ new technology VetGuardian, exotic animal veterinarians at the Akron (Ohio) Zoo have monitored mountain lions and more.
Read on »
Panbela Therapeutics, Inc., formerly Sun Biopharma, a UF startup and clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, has completed patient enrollment in its Phase 1 trial evaluating the safety and tolerability of SBP-101 when used in combination with standard of care agents gemcitabine and nab-paclitaxel for first-line treatment of patients with metastatic pancreatic ductal adenocarcinoma (PDA).
Read on »
They say knowledge is power. That philosophy is what drives Dr. Yiannis Ampatzidis, an assistant professor at the Southwest Florida Research and Education Center in Immokalee, where he leads the precision agriculture engineering program.
Read on »
Helena Cowley, MS, MBA, is CEO of UF Innovate | The Hub resident Oxidien Pharmaceuticals, a therapeutics company mitigating kidney stone disease by using enzyme compounds to treat secondary hyperoxaluria. Life Science Nation interviewed Cowley about the early days of Oxidien and how they’ve navigated the fundraising landscape. They discussed conferences, networking, and tools to... Read More
Read on »
A new study at the University of Florida suggests 3 common antihistamine drugs can be affective against coronavirus. Elliot Rodriguez sat with Dr. David Ostrov to discuss the topic.
Read on »
|
|
Feel free to contribute news you see online.
Send me an email with a link to an article we may have missed. We want to amplify good news whenever we can.
|
|
|
|
|
|
